Building Bridges for DVT Diagnosis: Rivaroxaban versus Enoxaparin Guideline Review and Discussion

Author: Dr Gary Mitchell
Type: MLP-research
Date: December 2021
Abstract:
Rivaroxaban is well established as a treatment for deep vein thrombosis and pulmonary embolism, but there has been hesitation in using it as a bridging agent in clinical situations where DVT is suspected but not yet confirmed by definitive ultrasound scan. The evidence for the safety and efficacy of this approach is explored. During this time of research, the use of rivaroxaban began to gain acceptance and usage in New Zealand, leading to a brief analysis of factors involved in trying to introduce up to date guidelines into a small health organisation in New Zealand prior to widespread acceptance and definitive guidelines at District Health Board level.

Cannabinoid Hyperemesis Syndrome

Author: Dr Sandy Crofts
Type: MLP-research
Date: December 2021
Abstract:
Cannabinoid Hyperemesis Syndrome (CHS) is a syndrome of intractable vomiting with severe abdominal pain that is associated with chronic marijuana use. Classically, symptoms are relieved by hot showers and are often unresponsive to traditional acute interventions such as antiemetics.
Patients commonly undergo multiple investigations without diagnosis.  Complete resolution of symptoms occurs with abstinence from cannabis. The following Medical Literature Project gives an overview of Cannabinoid Hyperemesis Syndrome and review of current management.

Is Adenosine safe for conversion of SVT in Urgent Care settings?

Author: Dr Imran Zia
Type: MLP-research
Date: December 2021
Abstract: A literature review was carried out to assess the safety of Adenosine in Urgent Care (UC) setting for the termination of Paroxysmal Supraventricular tachycardia (PSVT). Thorough literature evaluation advocates the use of adenosine for the acute termination of PSVT in Urgent care settings, especially in rural and remote practices. It has the potential to improve patient management and satisfaction along with a reduction in cost, ED load, and associated hospitalization.